NCT07543783 clinical trial report covering Adebrelimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600123143 clinical trial report covering Pucotenlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600123189 clinical trial report covering Bevacizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07545772 clinical trial report covering Brenipatide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07543848 clinical trial report covering Serplulimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07545759 clinical trial report covering Brenipatide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07545044 clinical trial report covering Anbenitamab repodatecan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07545746 clinical trial report covering Fluorouracil, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07545681 clinical trial report covering GSK-3772701, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07550387 clinical trial report covering HS-10380, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261596 clinical trial report covering HRXG-K-1939, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261504 clinical trial report covering Osimertinib mesylate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.